Purpose:This study examined what men from high-risk breast/ovarian cancer families valued from attending a familial cancer clinic. Methods: One hundred men from families with a BRCA1 or BRCA2 mutation completed a self-administered questionnaire. Results: Seventytwo percent (72%) of men attended the familial cancer clinic at the request of a family member. Multivariate analyses showed that men with a preference for a collaborative decision-making style (B ϭ Ϫ4.651, 95% CI ϭ Ϫ9.014 to Ϫ0.289, P ϭ 0.04), those with lower levels of education (B ϭ Ϫ4.850, 95% CI ϭ Ϫ9.16 to Ϫ0.537, P ϭ 0.03), and those with higher levels of cancer-related anxiety (intrusion) (B ϭ 0.920, 95% CI ϭ 0.441-1.399, P Ͻ 0.001) were more likely to value emotional support from the clinic. Men with a collaborative decision-making style (B ϭ Ϫ2.68, 95% CI ϭ Ϫ4.91 to Ϫ0.467, P ϭ 0.02) were less likely, and those with higher total levels of cancerrelated anxiety (intrusion and avoidance) (B ϭ 0.393, 95% CI ϭ 0.008 -0.779, P ϭ 0.04) were more likely to value receiving information from the clinic. Conclusions: A preference for collaborative decision making and cancer-related anxiety predicted men valuing information and emotional support from the consultation. The finding that men's attendance is initiated by family members highlights the value men place on family responsibility. Genet Med 2009:11(6):434 -440.Key Words: BRCA1 and BRCA2, men, familial cancer clinics, attendance, preferences, values T he main emphasis in genetic counseling and testing for hereditary breast/ovarian cancer is on female family members. In both sexes, germline BRCA1/2 mutations have been associated with elevated risks for cancers at multiple organ sites, including pancreas, stomach, gall bladder, and bile duct, as well as cutaneous and ocular melanoma. 1,2 The estimated cumulative lifetime risk for breast cancer in men with BRCA2 mutations is 6.9%. [3][4][5] Male BRCA2 carriers have an estimated lifetime risk of prostate cancer of between 6 and 14%. 6 -8 As the major risks conferred by mutations in BRCA1 and BRCA2 are related to cancer of the breast, ovary, fallopian tubes, and peritoneum, predictive testing among men is mainly offered by genetic services to clarify risks for other family members, particularly daughters. 9,10 This stance is supported by data suggesting that men do not believe that just knowing their mutation status is a sufficient motivation to have genetic testing. 11 They are motivated to seek genetic counseling and testing by concern for their daughters 11,12 and also may want to know their carrier status as a way of fostering family solidarity and supporting others through the process. 11 However, fewer men than women come forward for predictive BRCA1/2 testing 13-16 and men who do take up genetic counseling have a tendency to miss appointments, drop out of testing protocols 17,18 and experience difficulties in establishing appropriate posttest care. 12 Misinformation may be a barrier to attendance. 19 Women at risk because of a paternal family hi...